Digital Health Solutions for Patients With Type 2 Diabetes

Clinical Research of Digital Health Solutions for Patients With Type 2 Diabetes

We will conduct a prospective, single-center observational study involving 60 adult T2D patients recruited from Chang Gung Memorial Hospital. Participants will be randomly allocated to either a CGM group or a control group receiving standard care. The intervention group will utilize mobile apps for medication tracking, and a remote communication platform. All participants will collect clinical data-including HbA1c, Time in Range (TIR), insulin use-at baseline and 12 weeks. Patient adherence and satisfaction with CGM will also be assessed.

Inclusion Criteria:

- Patients with confirmed diagnosis of T2D for >1 year, capable of using a smartphone, and willing to sign informed consent.

Exclusion Criteria:

• Patients with severe cardiac, hepatic, or renal disease; pregnant women; those participating in other experimental treatments; or unable to follow up.